Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis

OBJECTIVES: The primary aim of our study was to evaluate long-term efficacy of secukinumab (SCK) in patients with axial spondyloarthritis (axSpA); secondary aims were to evaluate drug retention rate and to identify differences in the clinical and laboratory assessment according to axSpA clinical fea...

Descripción completa

Detalles Bibliográficos
Autores principales: Gentileschi, Stefano, Rigante, Donato, Sota, Jurgen, Lopalco, Giuseppe, Giannotta, Maria Grazia, Emmi, Giacomo, Di Scala, Gerardo, Iannone, Florenzo, Fabiani, Claudia, Frediani, Bruno, Cantarini, Luca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150683/
https://www.ncbi.nlm.nih.gov/pubmed/32317863
http://dx.doi.org/10.1155/2020/6983272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150683/
https://www.ncbi.nlm.nih.gov/pubmed/32317863
http://dx.doi.org/10.1155/2020/6983272

Ejemplares similares